Trials / Unknown
UnknownNCT03860090
Efficacy and Safety in Pacemaker and Defibrillator Implantation Via Cephalic Versus Axillary Vein Access (CEPHAX)
Prospective Randomized Comparison of Efficacy and Safety in Pacemaker and Defibrillator Implantation Via Cephalic Versus Axillary Vein Access. The CEPHAX Study.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Castilla-La Mancha Health Service · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial evaluates the efficacy and safety of axillary versus cephalic venous access in the pacemakers and defibrillators implantation. Half of participants will receive the implant via fluoroscopy guided axillary venous access and the other half will receive the implant via improved cephalic venous access.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Pacemaker implant | Implantation of endovenous cardiac stimulation device. |
| DEVICE | Defibrillator implant | Implantation of endovenous cardiac defibrillation device. |
| PROCEDURE | AXILLARY VEIN ACCESS | Fluoroscopy-guided axillary puncture to get vein access |
| PROCEDURE | CEPHALIC VEIN ACCESS | Optimized cephalic vein cutdown to get vein access |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2019-02-20
- Completion
- 2022-10-01
- First posted
- 2019-03-01
- Last updated
- 2019-03-01
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT03860090. Inclusion in this directory is not an endorsement.